Cannabigerol clinical trials
How each study uses cannabigerol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the cannabigerol studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Cannabigerol
- 3
Studies by the year they started
3 studies that test it; most in 2024 (2); 1 more planned to start later
| Year | Studies |
|---|---|
| 2022 | 1 |
| 2024 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 3
Raphael Pharma (1) · University of Arkansas, Fayetteville (1) · Washington State University (1) · Stanford University (1)
Studies
Open first, then newest update. How each study uses cannabigerol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- The Effects of Cannabis on Post Operative Recovery After Radical CystectomyNot yet recruitingEarly Phase 1Stanford UniversityNCT07577999Written as CannabigerolHow we know
- The Effects of Cannabigerol on Attention-Deficit/Hyperactivity DisorderCompletedPhase 2University of Arkansas, FayettevilleNCT06115603Written as CannabigerolHow we know
- Acute Effects of CannabigerolCompletedPhase 1Washington State UniversityNCT05257044Written as CannabigerolHow we know
- A Clinical Study to Assess the Efficacy of Cannabigerol in Patients with Active Rheumatoid Arthritis.Active, not recruitingNot applicableRaphael PharmaNCT06513507Written as Cannabigerol (CBG)How we know
Codes
What other systems call cannabigerol · ClinicalTrials.gg INT003071
- MeSH (NLM) C037036cannabigerolConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) J1K406072NCANNABIGEROLConfirmed NLM, Wikidata
- RxNorm 2464938One source FDA
- Wikidata Q412122cannabigerolConfirmed NLM, Wikidata
- DrugBank DB14734One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C037036 | cannabigerol | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | J1K406072N | CANNABIGEROL | Confirmed NLM, Wikidata |
| RxNorm | 2464938 | — | One source FDA |
| Wikidata | Q412122 | cannabigerol | Confirmed NLM, Wikidata |
| DrugBank | DB14734 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.